• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患者的冠状动脉血流储备受损:与肝纤维化有关。

Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis.

机构信息

Department of Gastroenterology, Marmara University School of Medicine, Tophanelioglu Cad. No: 13/15 Altunizade, 34662 Istanbul, Turkey.

出版信息

Atherosclerosis. 2010 Jul;211(1):182-6. doi: 10.1016/j.atherosclerosis.2010.01.049. Epub 2010 Feb 7.

DOI:10.1016/j.atherosclerosis.2010.01.049
PMID:20181335
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiovascular disease. Coronary flow reserve (CFR) is widely used to examine the integrity of coronary microvascular circulation. We evaluated the prevalence of impaired CFR in patients with biopsy-proven NAFLD. We also investigated the independent clinical, biochemical, and liver histology predictors of CFR in the setting of NAFLD.

METHODS

Fifty-nine consecutive patients with NAFLD and 77 age- and gender-matched controls were evaluated. CFR recordings were performed by transthoracic Doppler harmonic echocardiography. CFR>or=2.0 was considered normal.

RESULTS

CFR was significantly lower in patients with NAFLD than in controls (2.11+/-0.45 vs. 2.52+/-0.62, P<0.001). An impaired CFR (i.e. <2) was found in 25 NAFLD patients (42.4%) whereas all controls had normal CFR values (P<0.001). A stepwise linear regression analysis in NAFLD patients identified liver fibrosis scores as the only independent predictor of CFR values (beta=-0.60; t=-2.44, P=0.021).

CONCLUSION

Our findings indicate that in patients with biopsy-proven NAFLD: (a) an abnormal CFR is found in approximately 42.4% of cases, and (b) liver fibrosis scores are an independent predictor of depressed CFR.

摘要

背景

非酒精性脂肪性肝病(NAFLD)与心血管疾病风险增加相关。冠状动脉血流储备(CFR)广泛用于检查冠状动脉微血管循环的完整性。我们评估了经活检证实的 NAFLD 患者中 CFR 受损的患病率。我们还研究了 NAFLD 患者中 CFR 的独立临床、生化和肝脏组织学预测因素。

方法

评估了 59 例连续的 NAFLD 患者和 77 例年龄和性别匹配的对照者。通过经胸多普勒谐波超声心动图进行 CFR 记录。CFR≥2.0 被认为正常。

结果

NAFLD 患者的 CFR 明显低于对照组(2.11±0.45 对 2.52±0.62,P<0.001)。25 例 NAFLD 患者(42.4%)存在受损的 CFR(即<2),而所有对照组的 CFR 值均正常(P<0.001)。NAFLD 患者的逐步线性回归分析确定肝纤维化评分是 CFR 值的唯一独立预测因素(β=-0.60;t=-2.44,P=0.021)。

结论

我们的研究结果表明,在经活检证实的 NAFLD 患者中:(a)约 42.4%的患者存在异常的 CFR;(b)肝纤维化评分是 CFR 降低的独立预测因素。

相似文献

1
Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis.非酒精性脂肪性肝病患者的冠状动脉血流储备受损:与肝纤维化有关。
Atherosclerosis. 2010 Jul;211(1):182-6. doi: 10.1016/j.atherosclerosis.2010.01.049. Epub 2010 Feb 7.
2
Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease.循环中 vaspin 水平和心外膜脂肪组织厚度与非酒精性脂肪性肝病患者的冠状动脉血流储备受损相关。
Atherosclerosis. 2011 Jul;217(1):125-9. doi: 10.1016/j.atherosclerosis.2011.03.026. Epub 2011 Mar 29.
3
Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis.非酒精性脂肪性肝病患者中非糖尿病患者的微量白蛋白尿:与肝纤维化的关系。
Metabolism. 2010 Sep;59(9):1327-30. doi: 10.1016/j.metabol.2009.12.012. Epub 2010 Jan 22.
4
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.与正常丙氨酸氨基转移酶值相关的非酒精性脂肪性肝病的临床和组织学谱
Hepatology. 2003 Jun;37(6):1286-92. doi: 10.1053/jhep.2003.50229.
5
Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.人类非酒精性脂肪性肝病中的瘦素、胰岛素抵抗与肝纤维化
J Hepatol. 2004 Dec;41(6):943-9. doi: 10.1016/j.jhep.2004.08.020.
6
Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者血清中 vaspin、obestatin 和 apelin-36 的水平。
Metabolism. 2011 Apr;60(4):544-9. doi: 10.1016/j.metabol.2010.05.008. Epub 2010 Jun 26.
7
Clinical and functional determinants of coronary flow reserve in non-ischemic dilated cardiomyopathy: an echocardiographic study.非缺血性扩张型心肌病中冠状动脉血流储备的临床和功能决定因素:一项超声心动图研究
Int J Cardiol. 2005 Oct 20;105(1):46-52. doi: 10.1016/j.ijcard.2004.11.013.
8
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.非酒精性脂肪性肝病伴低内脏性肥胖患者的非酒精性脂肪性肝炎和纤维化风险。
J Hepatol. 2011 Jun;54(6):1244-9. doi: 10.1016/j.jhep.2010.09.037. Epub 2010 Nov 11.
9
[Clinical and histological features of non-alcoholic fatty liver disease].非酒精性脂肪性肝病的临床和组织学特征
Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):812-6.
10
Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy.原发性甲状旁腺功能亢进引起的冠状动脉微血管功能障碍在甲状旁腺切除术后得到恢复。
Circulation. 2012 Aug 28;126(9):1031-9. doi: 10.1161/CIRCULATIONAHA.111.081307. Epub 2012 Jul 19.

引用本文的文献

1
The Role of Exercise in Regulating the Generation of Extracellular Vesicles in Cardiovascular Diseases.运动在调节心血管疾病中细胞外囊泡生成中的作用
Rev Cardiovasc Med. 2024 Nov 4;25(11):392. doi: 10.31083/j.rcm2511392. eCollection 2024 Nov.
2
Cardiology Assessment of Patients Undergoing Evaluation for Orthotopic Liver Transplantation.接受原位肝移植评估患者的心脏科评估
J Soc Cardiovasc Angiogr Interv. 2022 Nov 25;2(1):100528. doi: 10.1016/j.jscai.2022.100528. eCollection 2023 Jan-Feb.
3
From NAFLD to MASLD: Meta-analysis and systematic review of NAFLD patients in Turkiye in terms of metabolic profile and MASLD potential.
从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病:土耳其非酒精性脂肪性肝病患者代谢特征及代谢功能障碍相关脂肪性肝病潜在风险的荟萃分析与系统评价
Hepatol Forum. 2024 Jul 2;5(3):126-138. doi: 10.14744/hf.2023.2023.0042. eCollection 2024.
4
The Network between Heart and Liver from the View of Persian Medicine Versus Conventional Medicine.从波斯医学与传统医学视角看心与肝的联系
Galen Med J. 2023 Apr 18;12:e2557. doi: 10.31661/gmj.v12i.2557. eCollection 2023.
5
How non-alcoholic fatty liver disease and cirrhosis affect the heart.非酒精性脂肪性肝病和肝硬化如何影响心脏。
Hepatol Int. 2023 Dec;17(6):1333-1349. doi: 10.1007/s12072-023-10590-1. Epub 2023 Sep 28.
6
Impacts of Non-alcoholic Fatty Liver Disease on Acute Coronary Syndrome: Evidence and Controversies.非酒精性脂肪性肝病对急性冠状动脉综合征的影响:证据与争议。
Curr Atheroscler Rep. 2023 Oct;25(10):751-768. doi: 10.1007/s11883-023-01146-7. Epub 2023 Sep 28.
7
Cardiac risk stratification of the liver transplant candidate: A comprehensive review.肝移植候选者的心脏风险分层:一项全面综述。
World J Transplant. 2022 Jul 18;12(7):142-156. doi: 10.5500/wjt.v12.i7.142.
8
New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis.非酒精性脂肪性肝病与冠状动脉疾病的新见解:肝-心轴
Life (Basel). 2022 Aug 4;12(8):1189. doi: 10.3390/life12081189.
9
Identification of Myocardial Insulin Resistance by Using Liver Tests: A Simple Approach for Clinical Practice.利用肝脏检查来识别心肌胰岛素抵抗:一种简单的临床实践方法。
Int J Mol Sci. 2022 Aug 7;23(15):8783. doi: 10.3390/ijms23158783.
10
Evaluation of liver transplant candidates with non-alcoholic steatohepatitis.对非酒精性脂肪性肝炎肝移植候选者的评估。
Transl Gastroenterol Hepatol. 2022 Jul 25;7:24. doi: 10.21037/tgh.2020.03.04. eCollection 2022.